Latest News:
OZEMPIC OR BUST
America has been trying to address the obesity epidemic for four decades
Zepbound and Wegovy do work, if you can get your insurance company to pay for them!
“The new drugs—and the “new understanding of obesity” that they have supposedly occasioned—could end up changing people’s attitudes toward body size. But in what ways? When the American Medical Association declared obesity a disease in 2013, Rebecca Puhl told me, some thought “it might reduce stigma, because it was putting more emphasis on the uncontrollable factors that contribute to obesity.” Others guessed that it would do the opposite, because no one likes to be “diseased.” Already people on these drugs are getting stigmatized twice over: first for the weight at which they started, and then again for how they chose to lose it.”
https://apple.news/AA8mXcq15ReyFsNLQiylduw
Why the obesity drug market is about to get a lot more crowded
“Not surprisingly, given the massive popularity of the obesity wunderkinds sold by Novo Nordisk and Eli Lilly, major competition is brewing.
In fact, analysts say the obesity drug market is about to get a lot more crowded, with more than a dozen new therapies poised to launch by decade’s end.”
Retatrutide
Triple–Hormone-Receptor Agonist Retatrutide for Obesity associated with 24% weight loss!
https://www.nejm.org/doi/full/10.1056/NEJMoa2301972
Comparison of GLP-1 Medications
Study shows Mounjaro (Zepbound) more effective than Ozempic (Wegovy)
https://www.medrxiv.org/content/10.1101/2023.11.21.23298775v1
CNMRI: Neurology, Sleep Medicine, MRI 